SCHEMBL13508148

SCHEMBL13508148

Cc1ccc(N(c2ccc(C)cc2)c2ccc3c4c5ccccc5c5c6ccc(N(c7ccc(C)cc7)c7ccc(C)cc7)cc6n(C)c5c4n(C)c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ TP53 P04637 2/20 0.40
▸ GABRP O00591 2/20 0.36
▸ GABRD O14764 2/20 0.36
▸ GABRA1 P14867 2/20 0.36
▸ GABRB1 P18505 2/20 0.36
▸ GABRG2 P18507 2/20 0.36
▸ GABRB3 P28472 2/20 0.36
▸ GABRA5 P31644 2/20 0.36
▸ GABRA3 P34903 2/20 0.36
▸ GABRA2 P47869 2/20 0.36
▸ GABRB2 P47870 2/20 0.36
▸ GABRA4 P48169 2/20 0.36
▸ GABRE P78334 2/20 0.36
▸ GABRA6 Q16445 2/20 0.36
▸ GABRG1 Q8N1C3 2/20 0.36
▸ GABRG3 Q99928 2/20 0.36
▸ GABRQ Q9UN88 2/20 0.36
▸ TOP2A P11388 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507560 0.97 TP53 (0.39) KDM4EMAPTTP53GABRPGABRD
SCHEMBL13507879 0.91 KDM4E (0.39) KDM4EMAPTGABRPGABRDGABRA1
SCHEMBL13507961 0.90 KDM4E (0.40) KDM4EMAPTTP53GABRPGABRD
SCHEMBL13507564 0.89 MAPT (0.37) KDM4EMAPTTP53GABRPGABRD
SCHEMBL13507964 0.89 MAPT (0.37) KDM4EMAPTTP53GABRPGABRD
SCHEMBL13511789 0.87 TP53 (0.36) KDM4EMAPTTP53ALKBH5FTO
SCHEMBL13508156 0.86 LIMK1 (0.43) KDM4EMAPTTP53GABRPGABRD
SCHEMBL18564752 0.85 KDM4E (0.37) KDM4EMAPTGABRPGABRDGABRA1
SCHEMBL13507554 0.85 KIF11 (0.38) KDM4EMAPTTP53GABRPGABRD
SCHEMBL13507568 0.84 BCHE (0.38) KDM4EMAPTTP53TOP2AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 KDM4E 3009/4885MAPT 2046/4885TP53 3874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback